The Neurofibromatosis Therapeutic Acceleration Program (NTAP) was established to accelerate the development of effective treatments for plexiform neurofibromas.

NTAP supports efforts that bridge the gap between early research discoveries and the clinic, ensuring people with plexiform neurofibromas can benefit from research advances as quickly as possible.

Francis S. Collins Scholars Program in Neurofibromatosis Clinical and Translational Research

Apply today, and help revolutionize the field of NF1 research!